Streetbeat News

Earnings

BIIB

Biogen reported its Q2 2024 results, with adjusted EPS of $5.28 beating the estimate of $4.03, and sales of $2.465 billion surpassing the expected $2.382 billion.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 10:58 am

ADT

ADT has reiterated its FY24 revenue guidance of $4.8B-$5.0B, with an adjusted EPS of $0.65-$0.75. The company has updated its EPS range to reflect the solar business as a discontinued operation.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 10:58 am

PWR

Quanta Services (NYSE:PWR) reported Q2 2024 adjusted EPS of $1.90, beating the estimate of $1.89. Sales were $5.594 billion, surpassing the $5.507 billion estimate and marking a 10.79% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 10:58 am

WBX

Wallbox reported Q2 revenue of €48.8 million, a 48% year-over-year increase, driven by strong performance in the North American market for both AC and DC sales.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 10:57 am

RACE

Ferrari reported Q2 sales of €1.71 billion, surpassing the estimated €1.61 billion.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 10:57 am

ADT

ADT reported its Q2 2024 adjusted EPS of $0.17, which was in line with expectations. However, the company missed its sales estimate, reporting $1.205 billion compared to the expected $1.210 billion.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 10:56 am

AME

AMETEK (NYSE:AME) reported Q2 2024 adjusted EPS of $1.66, beating the estimate of $1.64, but sales of $1.734 billion missed the $1.784 billion estimate. EPS increased by 5.73% year-over-year, while sales grew by 5.35%.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 10:56 am

EXC

Exelon has reaffirmed its FY24 adjusted EPS guidance of $2.40-$2.50, which is in line with the $2.44 estimate.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 10:54 am

APTV

Aptiv has lowered its FY24 revenue outlook to $20.10B-$20.40B, down from the previous range of $20.85B-$21.45B, and below the $21.03B estimate. The company also projects adjusted EPS of $6.15-$6.45, up from the prior view of $5.80-$6.30, and above the $6.03 estimate.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 10:54 am

EXC

Exelon (NASDAQ:EXC) reported Q2 2024 adjusted EPS of $0.47, beating the $0.40 estimate by 17.5%. Sales were $5.361 billion, surpassing the $4.897 billion estimate by 9.47%, and up 11.27% from last year's $4.818 billion.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 10:52 am